Use of hospice at end of life is significantly influenced by physician characteristics
the ONA take:
The strongest known predictor of whether a patient will enroll in hospice care is the individual physician the patient sees, according to new research from Brigham and Women’s Hospital.
This factor outweighs other known factors, including geographic location, patient age, race, and comorbidities.
After controlling for other factors that predict hospice enrollment, the researchers found that patients were 27% more likely to enroll in hospice if they saw a physician in the top 10% of hospice use, compared with those who saw a physician in the bottom 10%. In addition, they found that a large number of cancer patients were seen by a relatively small group of physicians.
Study results also showed that regional factors, greater comorbidity, and physician specialty were significantly associated with the likelihood of hospice enrollment.
A new effect seen in this study was physicians associated with for profit hospitals were less likely to have patients enroll in hospice, compared with physicians with non-profit hospitals.
The strongest known predictor of whether a patient will enroll in hospice care is the individual physician the patient sees.
Sign Up for Free e-newsletters
- Risk Factors for Arterial, Venous Thrombosis Differ in Polycythemia Vera
- Patient Satisfaction Ratings Can Be Negatively Impacted by Nurse Staffing Ratio
- Dietary Estrogens Reduced Efficacy of Novel Breast Cancer Therapy
- BRCA Mutation Improves Prognosis for 2-year Survival in Younger-onset TNBC
- Fosfomycin Effective Alternate for Febrile Neutropenia Prophylaxis
- Pertuzumab Regimen Approved for Adjuvant, Neoadjuvant Therapy in Specific Breast Cancers
- Common Oncologic Emergencies That Occur With Multiple Myeloma
- Artificial Sweeteners and Cancer Risk (Fact Sheet)
- Blueberry Extract May Boost Efficacy of Radiotherapy for Cervical Cancer
- Breast Implants Associated With Increased Risk of Breast Anaplastic Large-cell Lymphoma
- Resolving Vaginal Dryness in Women With a History of Breast Cancer
- Overall Survival Prolonged With HIPEC + Cytoreductive Surgery for Gastric Cancer
- Better Postoperative Outcomes With RAMIE for Esophageal Cancer
- Distinct Patterns of Shiny White Streaks Strong Indicator of Melanoma
- FDA Issues Warning for Rolapitant Injectable Emulsion in the Treatment of CINV
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|